EUVIMED · CrossrefZeitschrift
The American Journal of Gastroenterology Supplements
ISSN 1948-9498 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current Status
Intestine Microbes in Gastroenterology: Health and Disease
Postinfectious Chronic Gut Dysfunction: From Bench to Bedside
The Intestinal Microbiota and Liver Disease
Intestinal Microbes in Inflammatory Bowel Diseases
Impact of the Gut Microbiota on the Development of Obesity: Current Concepts
Methanogens in Human Health and Disease
Using Probiotics in Gastrointestinal Disorders
Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal Disorders
Continuing Medical Education: September 2014
Erratum: American Journal of Gastroenterology Supplements, Volume 2, Issue 1
Introduction: Opioid-Induced Constipation
The Use of Opioid Analgesics for Chronic Pain: Minimizing the Risk for Harm
Pharmacology of Opioids and their Effects on Gastrointestinal Function
Molecular Physiology of Enteric Opioid Receptors
The Narcotic Bowel Syndrome: A Recent Update
Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic Approach
An Evidence-Based Review of Novel and Emerging Therapies for Constipation in Patients Taking Opioid Analgesics
Erratum: American Journal of Gastroenterology Supplements, Volume 2, Issue 1
Introduction
Chronic Health Consequences of Acute Enteric Infections in the Developed World
Good Bugs, Bad Bugs in the Gut: The Role of Microbiota Dysbiosis in Chronic Gastrointestinal Consequences of Infection
The Microbiome–Gut–Brain Axis and the Consequences of Infection and Dysbiosis
Autoimmunity and Irritable Bowel Syndrome: New Pathophysiology
Genetics, Mucosal Inflammation and the Environment in Post-Infectious Chronic Gut Syndromes
Refining Treatment Paradigms in Inflammatory Bowel Disease: Assessing the Options for Individualized Therapy
Established Management Paradigms in IBD: Treatment Targets and Therapeutic Tools
Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current Status
Therapeutic Targets in Inflammatory Bowel Disease: Current and Future
Novel Therapies in Inflammatory Bowel Disease: An Evaluation of the Evidence
EUVIMED